Lipocine Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.47 | -$0.09 | -$0.78 |
| Q2 2024 | 1 | -$0.92 | -$0.05 | -$0.49 |
| Q3 2024 | 2 | -$0.40 | -$0.34 | -$0.37 |
| Q1 2025 | 1 | -$0.60 | -$0.04 | -$0.32 |
| Q2 2025 | 1 | -$0.59 | -$0.03 | -$0.31 |
| Q3 2025 | 1 | -$0.53 | -$0.03 | -$0.28 |
| Q4 2025 | 1 | -$0.25 | -$0.01 | -$0.13 |
Lipocine Inc. Earnings Date And Information
Lipocine Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.44 earnings per share for the quarter, topping analysts' consensus estimates of $-0.48 by $0.04. The company had revenue of 0 for the quarter and had revenue of -2,850,818 for the year. Lipocine Inc. has generated $-3 earnings per share over the last year ($-3.14 diluted earnings per share) and currently has a price-to-earnings ratio of -6.79. Lipocine Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based on prior year's report dates.
Lipocine Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.48 | -$0.41 | 0.07 | $129,500 | $0 |
| 08/08/2024 | Q2 2024 | -$0.78 | -$0.57 | 0.21 | $290,000 | $89,565 |
| 05/09/2024 | Q1 2024 | -$0.68 | $0.66 | 1.34 | $7.62 M | |
| 03/07/2024 | Q4 2023 | -$0.53 | -$0.43 | 0.1 | $216,188 | |
| 11/08/2023 | Q3 2023 | -$0.57 | -$1.27 | -0.7 | $307,000 | $-3,121,996 |
| 08/10/2023 | Q2 2023 | -$0.64 | -$0.68 | -0.04 | $256,000 | $0 |
| 05/11/2023 | Q1 2023 | -$0.42 | -$0.76 | -0.34 | $54,990 | |
| 03/10/2023 | Q4 2022 | $0.03 | -$0.43 | -0.46 | $0 | |
| 11/09/2022 | Q3 2022 | -$0.51 | -$0.52 | -0.01 | $698,667 | $0 |
| 08/08/2022 | Q2 2022 | -$0.68 | -$0.50 | 0.18 | $257,000 | $500,000 |
| 05/09/2022 | Q1 2022 | -$0.34 | -$0.67 | -0.33 | $0 | |
| 03/09/2022 | Q4 2021 | -$0.85 | $2.43 | 3.28 | $16.09 M | |
| 11/10/2021 | Q3 2021 | -$0.85 | -$0.59 | 0.26 | $54,994 | |
| 08/05/2021 | Q2 2021 | -$0.85 | -$1.31 | -0.46 | $0 | |
| 05/06/2021 | Q1 2021 | -$0.05 | -$0.70 | -0.65 | $0 | |
| 03/11/2021 | Q4 2020 | -$1.02 | -$1.15 | -0.13 | $0 | |
| 11/10/2020 | Q3 2020 | -$1.02 | -$1.13 | -0.11 | $0 | |
| 08/06/2020 | Q2 2020 | -$1.19 | -$2.18 | -0.99 | $0 | |
| 05/07/2020 | Q1 2020 | -$0.08 | -$2.37 | -2.29 | $0 | |
| 03/13/2020 | Q4 2019 | -$1.70 | -$1.83 | -0.13 | $0 |
Lipocine Inc. Earnings: Frequently Asked Questions
-
When is Lipocine Inc.'s earnings date?
Lipocine Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based off last year's report dates.
-
Did Lipocine Inc. beat their earnings estimates last quarter?
In the previous quarter, Lipocine Inc. (:LPCN) reported $-0.44 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.48 by $0.04.
-
How can I listen to Lipocine Inc.'s earnings conference call?
The conference call for Lipocine Inc.'s latest earnings report can be listened to online.
-
How can I read Lipocine Inc.'s conference call transcript?
The conference call transcript for Lipocine Inc.'s latest earnings report can be read online.
-
How much revenue does Lipocine Inc. generate each year?
Lipocine Inc. (:LPCN) has a recorded annual revenue of $-2,850,818.
-
How much profit does Lipocine Inc. generate each year?
Lipocine Inc. (:LPCN) has a recorded net income of $-2,850,818. Lipocine Inc. has generated $-3.14 earnings per share over the last four quarters.
-
What is Lipocine Inc.'s price-to-earnings ratio?
Lipocine Inc. (:LPCN) has a price-to-earnings ratio of -6.79 and price/earnings-to-growth ratio is -0.13.
